CHICAGO – In another strong indication of the emerging bioscience industry throughout the state, Gov. Rod R. Blagojevich announced today that Business Facilities Magazine’s July edition has ranked Illinois the top state in the nation for biotechnology. Illinois is at the center of a vibrant Midwest life sciences region that is leading the next generation of bioscience medical, agricultural, industrial and environmental solutions. With world-class research institutions, global companies and exceptional support resources, Illinois is putting science to work and creating good jobs throughout the state. Business Facilities defined biotechnology as encompassing a variety of different fields, including agricultural feedstock and chemicals, drugs and pharmaceuticals, medical devices and equipment, and research and testing.
"As the global economy continues to evolve, we are investing in the technologies of today and tomorrow. Business Facilities has recognized that these investments are paying important scientific and economic dividends. Illinois has all the necessary ingredients to not only lead the nation but also become the biotech capital of the world, and our important public-private partnerships involving our universities, national laboratories and industry leaders are helping us achieve this attainable goal. With Chicago hosting BIO 2006, one of the most prestigious international life sciences conference, the rapid growth of biotech throughout Illinois will certainly continue," Gov. Blagojevich said.
Business Facilities complied its rankings by examining a number of different factors, including the number of bioscience establishment, research parks and incubators, available financing and scientists in the workforce.
Over the last several months, Gov. Blagojevich has attracted some of the nation’s premier biotech firms to the Chicagoland area. Several leading pharmaceutical companies have decided to locate company headquarters or new facilities in the region, including Astellas Pharma and Takeda Pharmaceuticals North America in Deerfield and Hospira in Lake Forest. The state’s investments in these firms will help create and retain almost 2,000 jobs.
Unparalleled Concentration of Research and Institutions: With more than 200 academic, government and non-profit research institutions, Illinois has one of the largest concentrations of such facilities of any place in the world. Core facilities include:
Argonne National Laboratory – operates state-of-the-art research facilities, including the $20 billion Advanced Photon Source.
The Illinois Medical District – home to 40 research institutions including the Chicago Technology Park, one of the world’s first biotech research parks.
The University of Illinois has the second largest research budget in the U.S. with more than $700 million last year.
Deep Talent Pool: With more 44,000 biotech jobs in Illinois and more than 1.2 million people holding the professional services jobs that support the growth of life science companies, Illinois’ workforce will continue to infuse new and established companies with fresh energy and talent.
Diverse Life Science Applications: Illinois is home to the globe’s top life science companies, such as Abbott Laboratories, Baxter International, Archer Daniels Midland and Dade Behring, who are on the cutting-edge of research and commercialization encompassing drug discovery, agriculture and food, enabling technologies, and diagnostics and research tools.
Supporting Services: Illinois has seven research and tech parks and continues to develop state-of-the-art facilities, including quality office and wet-lab space, for emerging and developed technology companies. The 26-acre Illinois Science + Technology Park, being developed by Forest City Science + Technology Group, will significantly expand wet lab space and facilities available to the region’s life sciences community. This unprecedented Skokie facility that Gov. Blagojevich has already invested $1 million in is expected to create 3,250 new jobs on-site, more than 10,000 ripple-effect jobs and 1,000 construction jobs. Upon completion, the campus will generate $1.8 billion annually in statewide economic activity, according to a study conducted by Applied Real Estate Analysis, Inc.
"With our incredible universities, national labs and private industry, Illinois continues to be a birthplace for cutting-edge scientific research and innovation. Yet when it comes to acting as an engine of economic growth, our world-class scientific infrastructure has only scratched the surface of its enormous potential. Gov. Blagojevich recognizes the possibilities of biotech to help ensure a stronger and better future for Illinois, and has a plan to take advantage of it. We’re working simultaneously on two fronts – the first is investing in the infrastructure of biotechnology, to ensure we can take full advantage of our assets. The second is by marketing Illinois as a biotechnology leader, as evidenced by our landing of the BIO 2006 conference in Chicago. Business Facilities has recognized that the Governor’s strategic vision is working," Illinois Department of Commerce and Economic Opportunity Director Jack Lavin said.
"This recognition of the State of Illinois is the result of a long and salutary tradition, continued energetically by Gov. Blagojevich and Director Lavin, of making sound investments in our life sciences infrastructure. Their leadership, combined with world-class research institutions, a globally-recognized corporate community, and the state’s unmatched access to world markets, makes Illinois a compelling choice for companies seeking new or expanded locations," iBio President David Miller said.
You can find more information on the rankings at: http://www.businessfacilities.com/bf_05_07_ranking2.asp